Tong P

No ORCID on file · 1 paper in corpus
case-report 2021
OncoTargets and therapy ·doi:10.2147/ott.s309661

BACKGROUND: The optimal treatment and molecular landscape of recurrent clear cell carcinoma of the vulva (VCCC) are unknown. No reported data exist regarding the efficacy of anti-programmed death 1 (PD-1) immune checkpoint inhibition in VCC…